GOVX

GeoVax Labs Stock Price

2.68
0.04 (1.52%)
Upgrade to Real-Time
Afterhours (Closed)
2.68
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
GeoVax Labs Inc GOVX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.04 1.52% 2.68 17:00:00
Open Price Low Price High Price Close Price Previous Close
2.66 2.615 2.75 2.68 2.64
Bid Price Ask Price Spread News
2.65 2.72 0.07 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
588 149,499 $ 2.68 $ 400,085 992,558 2.56 - 4.40
Last Trade Time Type Quantity Stock Price Currency
14:03:53 formt 1,000 $ 2.6899 USD

GeoVax Labs Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 10.21M 3.81M 3.81M $ 1.18M $ - -86,256.34 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 245.60k -

more financials information »

GeoVax Labs News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GOVX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.772.77192.562.68146,680-0.09-3.25%
1 Month3.023.232.562.81199,281-0.34-11.26%
3 Months3.004.402.563.31798,221-0.32-10.67%
6 Months3.004.402.563.31798,221-0.32-10.67%
1 Year3.004.402.563.31798,221-0.32-10.67%
3 Years3.004.402.563.31798,221-0.32-10.67%
5 Years3.004.402.563.31798,221-0.32-10.67%

GeoVax Labs Description

Geovax Labs Inc is US-based clinical-stage biotechnology company. It is engaged in developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle (MVA-VLP) vector vaccine platform. The development programs of the company focused on preventive vaccines against Human Immunodeficiency Virus (HIV), Zika Virus, hemorrhagic fever viruses, and malaria, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers. The product pipeline includes HIV-Clade B Preventive Vaccine, HIV-Clade B Immunotherapy, Hemorrhagic Fever Vaccines, Zika Vaccine, Malaria vaccine, and Cancer Immunotherapy.


Your Recent History
NASDAQ
GOVX
GeoVax Lab..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.